All lobbying filings

Zimmer Biomet, Inc.

Zimmer Biomet, Inc. filed a Q2 report for Zimmer Biomet, Inc. on July 15, 2025.

Lobbying for Zimmer Biomet, Inc.

As filed: ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC.

All filings by Zimmer Biomet, Inc. · Everything Zimmer Biomet, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 15, 2025

Expenses

$190,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 6

Medicare/Medicaid

Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment

Trade (domestic/foreign)

Trade Issues/Policy

Taxation/Internal Revenue Code

Tax Issues

Environment/Superfund

EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS

Science/Technology

Medical Device Electronic Labeling Act (H.R. 1539)

Health Issues

Assorted issues related to the FDA

Bills named in this filing 1

H.R. 1539
Medical Device Electronic Labeling Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.